|
TMEM199 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.368600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.157000E-01 |
| Normal-vs-Stage2 |
5.677200E-01 |
| Normal-vs-Stage3 |
3.337400E-01 |
| Normal-vs-Stage4 |
4.626100E-02 |
| Stage1-vs-Stage2 |
5.409200E-01 |
| Stage1-vs-Stage3 |
3.409400E-01 |
| Stage1-vs-Stage4 |
1.104620E-01 |
| Stage2-vs-Stage3 |
6.874600E-01 |
| Stage2-vs-Stage4 |
3.351400E-01 |
| Stage3-vs-Stage4 |
6.848400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.098400E-01 |
| Normal-vs-AfricanAmerican |
1.940850E-01 |
| Normal-vs-Asian |
2.778600E-01 |
| Caucasian-vs-AfricanAmerican |
8.819700E-02 |
| Caucasian-vs-Asian |
5.235800E-01 |
| AfricanAmerican-vs-Asian |
8.712200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.133800E-01 |
| Normal-vs-Female |
9.850800E-01 |
| Male-vs-Female |
9.198400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.008800E-01 |
| Normal-vs-Extreme_Weight |
7.602600E-01 |
| Normal-vs-Obese |
8.382400E-01 |
| Normal-vs-Extreme_Obese |
9.992800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.521400E-01 |
| Normal_Weight-vs-Obese |
4.268600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.247400E-01 |
| Extreme_Weight-vs-Obese |
6.740000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.033400E-01 |
| Obese-vs-Extreme_Obese |
9.307600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.030600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.626040E-01 |
| Normal-vs-Age(61-80Yrs) |
1.580390E-01 |
| Normal-vs-Age(81-100Yrs) |
1.722640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.532800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.857700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.282000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.497800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.127800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.386600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.923500E-02 |
| Normal-VS-Type2 PRCC |
1.202220E-01 |
| Normal-VS-KIRP CIMP |
1.842640E-03 |
| Normal-VS-Unclassified PRCC |
9.730800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.978000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.302360E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.066400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.589800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.825200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.022970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.548800E-01 |
| Normal-vs-N1 |
1.905410E-01 |
| Normal-vs-N2 |
3.918600E-01 |
| N0-vs-N1 |
4.916400E-01 |
| N0-vs-N2 |
4.984400E-01 |
| N1-vs-N2 |
7.388400E-01 |
|
|
